5-meo-dmt
Small moleculeexperimental
Clinical trial activity
10 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2021 (NCT05032833)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06816667 | Phase 1/Phase 2 (Phase 2) | Oct 21, 2024 | Biomind Labs Inc. |
| NCT05870540 | Phase 2 | Sep 14, 2023 | Beckley Psytech Limited |
| NCT05674929 | Phase 2 | May 30, 2023 | Beckley Psytech Limited |
| NCT05800860 | Phase 2 | May 24, 2023 | GH Research Limited |
| NCT05839509 | Phase 2 | Apr 6, 2023 | GH Research Limited |
| NCT05804708 | Phase 2 | Mar 2, 2023 | GH Research Limited |
| NCT05660642 | Phase 2 | Jan 31, 2023 | Beckley Psytech Limited |
| NCT05698095 | Phase 1 | Dec 27, 2022 | Usona Institute |
| NCT05347849 | Phase 1 | Feb 14, 2022 | Beckley Psytech Limited |
| NCT05032833 | Phase 1 | Sep 30, 2021 | Beckley Psytech Limited |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Beckley Psytech Limited | For profit | 5 | 5 | 2 | 2021 |
| GH Research Limited | For profit | 3 | 3 | 1 | 2023 |
| Biomind Labs Inc. | For profit | 1 | 1 | 1 | 2024 |
| Usona Institute | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1